Si Qiu

Title: Si Qiu - Innovator in Tumor Immunotherapy

Introduction

Si Qiu is a prominent inventor based in Hubei, China. He has made significant contributions to the field of tumor immunotherapy. His innovative work focuses on developing polypeptides that can be utilized in the prevention and treatment of tumors.

Latest Patents

Si Qiu holds a patent for a "Tumor immunotherapy polypeptide and application thereof." This patent includes a polypeptide designed for tumor immunotherapy, which comprises at least one polypeptide from a first peptide group. Additionally, it may include polypeptides from a second peptide group. The first peptide group consists of polypeptides with specific amino acid sequences, while the second group includes additional polypeptides. The patent also covers various applications, including isolated nucleic acids, constructs, expression vectors, host cells, pharmaceutical compositions, antigen-presenting cells, immune effector cells, tumor vaccines, and methods for treating patients suffering from tumors.

Career Highlights

Si Qiu is associated with Genoimmune Therapeutics Co., Ltd., where he continues to advance his research in immunotherapy. His work has the potential to significantly impact cancer treatment and improve patient outcomes.

Collaborations

Si Qiu collaborates with Youping Li, contributing to the development of innovative therapeutic solutions.

Conclusion

Si Qiu's contributions to tumor immunotherapy exemplify the importance of innovation in medical science. His work not only advances the field but also offers hope for effective cancer treatments.